Study suggests biological age can be reduced

By The Science Advisory Board staff writers

June 29, 2020 -- A pilot study conducted by TruMe Labs for Ponce de Leon Health suggests that biological age can be reduced, the company reported.

The study, performed by Yelena Budovskaya, PhD, co-founder of TruMe Labs, showed that Ponce de Leon Health's Rejuvant LifeTabs reduced the biological age of users by an average of 8.5 years. Biological age is assessed via a DNA biomarker test that measures DNA methylation, according to the firm. LifeTabs contain a proprietary active ingredient, LifeAKG, which has been shown in preclinical animal studies to increase the lifespan and healthspan (length of healthy life) in mammalian models.

Ponce de Leon is currently enrolling participants in a randomized, double-blind, placebo-controlled clinical trial that will be conducted at Indiana University Medical Center later this year.

Ponce de Leon distributes TruMe's TruAge Index, a home-use epigenetic age test, it said. Ponce de Leon has eight patents pending for TruAge-related inventions.

From DNA to precision medicine, researchers discuss breakthroughs in cancer research
From the use of novel technologies such as machine learning and CRISPR, to gaining a deeper understanding of the genetic and molecular drivers of cancer,...
Precision medicine and molecular understanding of illness
The current era of scientific research is seen by many as a golden age of discovery in genetics, due to rapid progress in numerous areas of science and...
Algorithm provides new insight into hierarchical DNA structures that influence disease
Researchers develop an algorithm that locates specific topologically associating domains (TADs) which are implicated in disease development, including...
Researchers work out the early steps that drive malignancy
Researchers from Yale University have identified cellular characteristics that lead to the early stages of malignancy. They state that in at least one...

Copyright © 2020

Register below for our weekly Letter from the Editor to receive the latest Science news and insights.
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter